Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
Madhusubramanian Muthukumar,1 Kamal Desai,1 Seye Abogunrin,2 Timothy Harrower,3 Sylvie Gabriel,4 Jerome Dinet5 1Modelling and Simulation, 2Meta Research, Evidera, London, 3Royal Devon and Exeter NHS Foundation Trust, Exeter, UK; 4Global Market Access and Pricing, 5Health Economics and Outco...
Saved in:
Main Authors: | Muthukumar M (Author), Desai K (Author), Abogunrin S (Author), Harrower T (Author), Gabriel S (Author), Dinet J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
by: Abogunrin S, et al.
Published: (2015) -
AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis
by: Carlo Lazzaro, et al.
Published: (2020) -
Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
by: Rungsima Wanitphakdeedecha, et al.
Published: (2020) -
Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy
by: Carlo Di Gregorio, et al.
Published: (2023) -
Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study
by: Rappl T, et al.
Published: (2013)